1. Prevalence of methicillin—resistant Staphylococcus aureus in eight African hospitals and Malta
- Author
-
K. Rahal, C N Kesah, M. Benbachir, Tolu Odugbemi, M. Dosso, Sinata Koulla-Shiro, C.S. Boye, S. Ben Redjeb, Michael Borg, J.O. Ndinya Achola, Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Hôpital Charles Nicolle [Tunis], Institut Pasteur de Côte d'Ivoire, Réseau International des Instituts Pasteur (RIIP), CHU Le Dantec, University of Nairobi (UoN), University of Yaoundé [Cameroun], CHU Ibn Rochd, CHU Ibn Rochd [Casablanca], Institut Pasteur d'Algérie, St Luke's Hospital, and This work was supported by the Africa medical department of Smithkline Beecham International
- Subjects
Veterinary medicine ,Micrococcaceae ,Antibiotics ,Drug resistance ,MRSA ,MESH: Africa ,medicine.disease_cause ,susceptibility ,0302 clinical medicine ,Prevalence ,MESH: Staphylococcus aureus ,030212 general & internal medicine ,Antibacterial agent ,0303 health sciences ,MESH: Microbial Sensitivity Tests ,biology ,General Medicine ,Staphylococcal Infections ,Drug Resistance, Multiple ,3. Good health ,Infectious Diseases ,Staphylococcus aureus ,MESH: Malta ,Vancomycin ,medicine.drug ,Microbiology (medical) ,medicine.drug_class ,MESH: Staphylococcal Infections ,Microbial Sensitivity Tests ,Staphylococcal infections ,Microbiology ,MESH: Drug Resistance, Multiple ,03 medical and health sciences ,medicine ,Humans ,MESH: Prevalence ,MESH: Humans ,MESH: Methicillin Resistance ,030306 microbiology ,business.industry ,Malta ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,medicine.disease ,bacterial infections and mycoses ,Methicillin-resistant Staphylococcus aureus ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Africa ,Methicillin Resistance ,business - Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) poses a serious therapeutic problem worldwide, and its frequency in most African countries has not been reported. This study was aimed at determining the prevalence and antibiotic susceptibility patterns of MRSA in eight large hospitals (>500 beds) in Africa and Malta, from 1996 to 1997. Susceptibility to methicillin (oxacillin) and to other drugs was determined by E test (AB Biodisk, Solna, Sweden) on a total of 1440 clinical isolates of S. aureus. Methicillin resistance was detected in 213 (15%) of the 1440 isolates tested. The rate of MRSA was relatively high in Nigeria, Kenya, and Cameroon (21-30%), and below 10% in Tunisia, Malta, and Algeria. All MRSA isolates were sensitive to vancomycin, with MICs≤4mg/L. The isolates were also highly sensitive to ciprofloxacin, except in Kenya, Morocco, and Tunisia, where relative resistance to this drug was noted. Susceptibility to rifampin and fusidic acid seems to be correlated with the clinical use of these compounds. Only 46% of 59 MRSA strains analyzed were susceptible to rifampin, fusidic acid, and ciprofloxacin. The majority (>60%) of MRSA strains were multiresistant. There is a need to maintain surveillance and control of MRSA infections in Africa.
- Full Text
- View/download PDF